At Merck Frosst Canada, I have been an integral part of the discovery of a new molecule, the
testing of its mechanism of action, the validation of its safety and efficacy in
Phase IIb and III clinical trials, the market approval of the resulting product, and the
subsequent management of patients and their disease.